| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | CA2500977A1 2-thiohydantoine derivative compounds and use thereof in therapeutics |
| 04/15/2004 | CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | CA2500935A1 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/15/2004 | CA2496565A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/14/2004 | EP1408038A2 Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 04/14/2004 | EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406617A1 Diaminediols for the treatment of alzheimer's disease |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 04/14/2004 | EP1028110B1 Novel dihydronaphthalene compounds and process for producing the same |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720323 Colchinol derivatives as angiogenesis inhibitors |
| 04/08/2004 | WO2004029007A1 Use of 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy as an agent for stopping polymerisation in the production of alkylimidazolidone (meth)acrylates |
| 04/08/2004 | WO2004029004A1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2002032856A9 Insecticidal 1,8-naphthalenedicarboxamides |
| 04/08/2004 | US20040068012 Anticancer agents; protease enzyme inhibitor |
| 04/08/2004 | US20040067996 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 04/08/2004 | US20040067988 Anticoagulants |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | CA2500206A1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis |
| 04/07/2004 | EP1404696A1 Activators for oligonucleotide synthesis |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | CN1487941A Synthesis of temozolomide and analogs |
| 04/07/2004 | CN1487924A Farnesyl transferase inhibitors |
| 04/07/2004 | CN1487916A Process for the preparation of arylethanoldiamines useful as agonists the beta-3-adrenoceptor |
| 04/07/2004 | CN1487821A Novel couplers for use in oxidative hair dyeing |
| 04/07/2004 | CN1487820A Primary intermediate for oxidative coloration of hair |
| 04/07/2004 | CN1487815A Novel couplers for use in oxidative hair dyeing |
| 04/06/2004 | US6717008 Use as anorectics, treating obesity and type ii diabetes; c2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group |
| 04/06/2004 | US6716990 Process and intermediates for the preparation of imidazopyridines |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063772 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-pyrazolecarboxylic acid, 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-(2-furyl)pyrazole, and imidazole |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063762 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063026 Dry film photoresist |
| 04/01/2004 | DE10243666A1 Dithiocarbaminsäureester Dithiocarbaminsäureester |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1403709A2 Photoinitiator |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1403235A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401844A2 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same |
| 03/31/2004 | EP1401452A1 Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401432A2 Imidazole derivatives for modulating sodium channels |
| 03/31/2004 | EP1250049B1 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties |
| 03/31/2004 | CN1486319A Synthesis of temozolomide and analogs |
| 03/31/2004 | CN1486297A Primary intermediates for oxidative coloration of hair |
| 03/31/2004 | CN1485316A Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/31/2004 | CN1143674C Refractory vasculitis therapeutic agent |
| 03/30/2004 | US6713647 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/30/2004 | US6713632 Process for the preparation of imidazole derivatives |
| 03/30/2004 | US6713631 Preparation method of 2,2'-bi-1H-imidazole using glyoxal and an ammonium salt |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | US6713500 Agent for controlling animal diseases caused by parasites |
| 03/30/2004 | US6713496 3-(imidazolyl)-2-alkoxypropanoic acids |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/25/2004 | WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren |
| 03/25/2004 | WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors |
| 03/25/2004 | WO2004024698A1 1-sulphonyl piperidine derivatives |
| 03/25/2004 | WO2004024697A1 Amine compounds and use thereof |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2004024060A2 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 03/25/2004 | WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis |